Where does Xtreme Orthopedics LLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Xtreme Orthopedics LLC ranks #18,307 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Xtreme Orthopedics LLC hold?

Xtreme Orthopedics LLC holds 16 US utility patents granted between 2017 and 2024, spanning 3 technology areas.

What is Xtreme Orthopedics LLC's Innovation Score?

Xtreme Orthopedics LLC has an Innovation Score of 24.9 out of 100 (16th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Xtreme Orthopedics LLC's patent grant rate increasing or decreasing?

Xtreme Orthopedics LLC's recent grant velocity is +0% compared to the prior five-year period (grant years, not application filing dates). The company is maintaining or growing its granted-patent output.

What does claim depth mean for Xtreme Orthopedics LLC's patents?

Xtreme Orthopedics LLC's patents average 7.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Xtreme Orthopedics LLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Xtreme Orthopedics LLC

Q: What technology areas does Xtreme Orthopedics LLC focus on?

Xtreme Orthopedics LLC's top technology area is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs) with 6 patents, ranking #1,036 of 3,082 assignees active in that subclass. Grants appear in 3 CPC subclasses total.

USPTO PatentsView assignee record - 16 granted patents across 3 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Xtreme ranks #18,307 of 49,997 tracked US assignees by granted-patent volume, with 16 patents across 3 technology areas.

#18,307
of 49,997 US assignees by volume: 16th percentile
by Innovation Score (24.9/100): 7.6
avg claims per patent: +0%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18307 · US Corporation #18,307 · 16 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · VEL-FLAT · BOOK-FULL

GRANTS-MICRO 16 grants
MID-PACK #18,307/49,997
PHOTO-FINISH X4 Pharmaceuticals
CPC-NARROW A61F · 3 areas
INNOV-THIN 24.9/100
CLAIMS-SPARSE 7.6 claims/avg
TYPE-USCORP US Corporation
VEL-FLAT +0% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: X4 Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Xtreme’s 24.9 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.8 pts (40%) Velocity 4.4 pts (18%) Breadth 6.1 pts (25%) Claim depth 4.5 pts (18%)

Qualcomm Incorporated · highest

85
Xtreme Orthopedics · this assignee

25
3D Lighting… · lowest

7

What this shows Xtreme's Innovation Score is 24.9/100 (16th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Xtreme?

Each dot is one of Xtreme’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Xtreme’s own 7.6 claims/patent is at or below the 14.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Xtreme vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Xtreme's grants concentrate

Xtreme Orthopedics LLC is a focused PatentsView assignee: 3 CPC subclasses with 37.5% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2017 (6 grants) versus a trough of 2 in 2019. By volume, Xtreme sits between X4 Pharmaceuticals, Inc. and YLX Incorporated.

Xtreme's three-year grant acceleration

Xtreme Orthopedics LLC shows 4 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

X4 Pharmaceuticals

16
Xebec Technology

16
Xenotherapeutics

16
Xi'an Creation Ke…

16
XY

16
Xidrone Systems

16
Xockets

16
YLX Incorporated

16
Xtreme Orthopedics ◀

16

What this shows Xtreme holds 16 patents at rank #18,301, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Xtreme

By rank, the assignees closest to #18,301 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Xtreme's primary technology class.

Xtreme's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 16th percentile higher than 16% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Xtreme Orthopedics LLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	6	37.5%
2019	2	12.5%
2020	2	12.5%
2021	2	12.5%
2023	2	12.5%
2024	2	12.5%

Which technologies does Xtreme Orthopedics LLC patent most?

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 6

A61H - Physical Therapy Apparatus, e.g. Devices FOR Locating OR Stimulating Reflex Points IN THE BODY; Artificial RESPIRATION; MASSAGE; Bathing Devices FOR Special Therapeutic OR Hygienic Purposes OR Specific Parts OF THE Body 2

A61B - DIAGNOSIS; SURGERY; Identification 1

Top 3 of 3 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Xtreme Orthopedics LLC's patent record in context - here's where to go next.

Xtreme Orthopedics LLC's lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 37.5% of its portfolio - see every assignee active in that class. Explore A61F
Ranked #18,307 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Xtreme Orthopedics LLC against X4 Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 24.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.